Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
EXEL
Exelixis
$40.09
Login to see Exelixis (EXEL) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Trading below its fair value
Outperform the market
Chart
$38.28 (+4.73%)
$45.58 (-12.04%)
$44.44 (-9.79%)
$28.9 (+38.72%)
EXEL has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
EXEL overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
EXEL Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EXEL Street view is extremely bullish and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayEXEL Earnings
The TTM reflects 12-month period, providing review of EXEL financial performance.
The company financial health has moderately improved over the past year
Financial Score
RVMD
46.71
+2.21%
BNTX
105.49
+0.94%
AMGN
297.89
+0.16%
AGEN
4.14
+5.08%
What is EXEL current stock price?
What are EXEL stock strengths?
What risks are associated with EXEL stock?
When is EXEL next earnings report?
What is EXEL market cap and volume?
What is EXEL's current Stock IQ?
Should I buy EXEL stock right now?
Is EXEL a Strong Buy right now?
What does a 'Strong Buy' rating mean for EXEL?
What does a 'Strong Sell' rating mean for EXEL?
What factors influence EXEL's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
EXEL
Exelixis
Current Price
$40.09
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Trading below its fair value
Outperform the market
Linked to EXEL
RVMD
46.71
+2.21%
BNTX
105.49
+0.94%
AMGN
297.89
+0.16%
AGEN
4.14
+5.08%
Login to unlock Exelixis (EXEL) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$38.28 (+4.73%)
$45.58 (-12.04%)
$44.44 (-9.79%)
$28.9 (+38.72%)
EXEL Analysts Opinion
EXEL Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Above analyst estimates
Revenue declined YoY
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Price value has negative momentum
Activity
Activity
Future
Future
Earnings are forecast to grow
Trading below its fair value
Outperform the market
EXEL Analysts opinion is negative but has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
EXEL Street view is extremely bullish and have negative views on the near-term outlook
EXEL has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayEXEL Earnings
The TTM data reflects the most recent 12-month period, providing overview of EXEL financial performance.
EXEL Financial Health
The company financial health has moderately improved over the past year
Financial Score
EXEL Latest Analysis
Morgan Stanley Maintains Overweight Rating For Exelixis Inc. (EXEL) Price Target Raised To $50.
Fri Sep 26, 2025
Exelixis Inc. (EXEL) Presents at Bernstein 2nd Annual Global Healthcare Conference Transcript.
Wed Sep 24, 2025
Goldman Sachs Initiates Coverage of Exelixis (EXEL) with Buy Recommendation. Fintel reports that on September 17 2025 Goldman Sachs initiated coverage of Exelixis (NasdaqGS:EXEL) with a Buy recommendation.
Thu Sep 18, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
EXEL Stock trends
EXEL Stock performance
EXEL Stock analysis
EXEL investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings